SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after reporting its first-ever quarterly profit and strong delivery guidance, sparking broad optimism that the company is entering a new, healthy business cycle. The community is actively discussing the significance of this profitability milestone, its multi-brand strategy, and in-house AI chip development, with some debate around CEO compensation.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending strongly after its latest earnings report highlighted robust growth in cloud and AI infrastructure, driven by a record backlog of performance obligations and a major deal with OpenAI. This has sparked widespread community discussion about a significant market repricing and potential short squeeze for the AI cloud leader.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending after its recent S&P 500 exclusion triggered significant selling and investor frustration over persistent dilution and macro headwinds, though many continue to accumulate shares, highlighting strong revenue growth, profitability, and strategic ventures like its new bank-backed stablecoin.

AeroVironment, Inc. engages in the design, development, and production of multi-domain robotic systems and related services for government agencies and businesses. It operates through the following business segments: UnCrewed Systems, Loitering Munitions Systems, and MacCready Work. The UnCrewed Systems segment focuses primarily on small UAS products designed to operate reliably at lower altitudes in a wide range of environmental conditions. The Loitering Munitions Systems segment focuses primarily on tube-launched aircraft that deploy with the push of a button, fly at higher speeds than small UAS products, and perform either effects delivery or reconnaissance missions, and related support services including training, spare parts, product repair, and product replacement. The MacCready Works segment focuses on customer-funded research and development in the areas of HAPS, robotics, sensors, software analytics, data intelligence, and connectivity. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending following a significant stock dip caused by reports regarding the U.S. Space Force's SCAR program, leading many investors to debate if the sell-off is an overreaction given the company's active negotiations for the contract and robust demand for its defense drone technology amid global events.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is trending due to the proposed Mission 70 tokenomics, aiming to drastically reduce inflation, and growing real-world adoption of its decentralized cloud infrastructure through new national subnets. While some in the community see these developments as strong fundamental drivers for future growth in AI and Web3, others remain skeptical, citing historical price struggles and perceived market manipulation.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is trending following robust earnings that showcased strong CARVYKTI sales and the CAR-T therapy achieving franchise profitability for 2025, alongside a solid cash runway beyond 2026. The community is actively discussing the stock's perceived undervaluation, potential for a short squeeze, and substantial upside from its expanding market opportunities and manufacturing scale.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

Dexcom is trending following strong preliminary Q4 revenue exceeding expectations, robust 2026 guidance, and new clinical data showing the G7's effectiveness for Type 2 non-insulin diabetes. The community is actively discussing analyst upgrades and anticipating further upside from the G7 15-day rollout and potential broader Medicare coverage, amidst ongoing conversations about product reliability and market competition.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is trending following a convertible notes offering that has fueled widespread accusations of stock manipulation and shareholder value suppression on NASDAQ, despite a recent patent dispute victory and the anticipated benefits from its U.S. manufacturing ramp and valuable Recurrent Energy assets.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is trending due to its strategic expansion into the healthcare sector via the Diligent Robotics acquisition and a recent endorsement from NVIDIA's CEO, igniting community debate around its high short interest and upcoming earnings in the dynamic AI and robotics space.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the FDA has lifted a Complete Response Letter for its Duchenne Muscular Dystrophy therapy, deramiocel, and set a new PDUFA date, a move amplified by the imminent departure of a key FDA official whom the community largely considered a major regulatory hurdle. This has ignited widespread speculation among investors about an accelerated approval, potential M&A, and a significant short squeeze, especially with anticipated clinical data presentations approaching.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Barclays PLC Purchases 696,447 Shares of Progyny, Inc. $PGNY

Barclays PLC boosted its holdings in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 79.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...

Quantbot Technologies LP Reduces Stock Position in Progyny, Inc. $PGNY

Quantbot Technologies LP decreased its holdings in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 68.6% during the third quarter, according to the company in its most recent disclosure with the...

Progyny, Inc. $PGNY Shares Bought by Dynamic Technology Lab Private Ltd

Dynamic Technology Lab Private Ltd increased its stake in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 555.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The...

Progyny (NASDAQ:PGNY) EVP Sells $10,506.46 in Stock

Progyny, Inc. (NASDAQ:PGNY - Get Free Report) EVP Allison Swartz sold 599 shares of the company's stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $17.54, for...

BTIG Research Lowers Progyny (NASDAQ:PGNY) Price Target to $30.00

BTIG Research reduced their target price on Progyny from $35.00 to $30.00 and set a "buy" rating for the company in a report on Thursday...

Allison Swartz Sells 4,657 Shares of Progyny (NASDAQ:PGNY) Stock

Progyny, Inc. (NASDAQ:PGNY - Get Free Report) EVP Allison Swartz sold 4,657 shares of the firm's stock in a transaction that occurred on Tuesday, March 3rd. The shares were sold at an average price...

Progyny, Inc. (NASDAQ:PGNY) Given Average Rating of "Moderate Buy" by Brokerages

Progyny, Inc. (NASDAQ:PGNY - Get Free Report) has been given an average rating of "Moderate Buy" by the twelve brokerages that are presently covering the company, Marketbeat.com reports. Four...

Progyny (NASDAQ:PGNY) EVP Allison Swartz Sells 2,199 Shares

Progyny, Inc. (NASDAQ:PGNY - Get Free Report) EVP Allison Swartz sold 2,199 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price...

Insider Selling: Progyny (NASDAQ:PGNY) EVP Sells 4,657 Shares of Stock

Progyny, Inc. (NASDAQ:PGNY - Get Free Report) EVP Allison Swartz sold 4,657 shares of the business's stock in a transaction on Tuesday, March 3rd. The stock was sold at an average price of $17.40...

JPMorgan Chase & Co. Trims Position in Progyny, Inc. $PGNY

JPMorgan Chase & Co. trimmed its holdings in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 28.1% in the 3rd quarter, according to the company in its most recent 13F filing with the...

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm’s network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.

Current Price	$17.91
Prev Close	$18.25
Open	$18.32
Dividend Yield	0.00%
50-Day Moving Average	$23.07
Beta	0.63
Avg. Volume	1.58M
PE Ratio	27.96

52-Week High	$28.75
52-Week Low	$16.76
Market Capitalization	$1.49B
EPS (Annual)	$0.6512
Price to Book	2.95
Revenue Per Employee	$1.51M

PGNY
Progyny Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PGNY News

PGNYProgyny Inc